Annual report [Section 13 and 15(d), not S-K Item 405]

Other current assets (Tables)

v3.25.1
Other current assets (Tables)
12 Months Ended
Dec. 31, 2024
Other current assets  
Summary of other current assets

Other current assets consisted of the following (in thousands):

​

​

​

​

​

​

​

​

​

December 31, 

​

December 31, 

​

    

2024

​

2023

Research and development credits receivable

 

$

12,929

​

$

46,098

Prepayments

 

​

10,033

​

​

9,954

Clinical materials

 

​

59

​

​

1,329

VAT receivable

​

​

1,599

​

​

—

Other current assets

 

​

3,170

​

​

2,412

​

​

$

27,790

​

$

59,793